Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
The skeleton supports and confers structure to the whole body but several pathological and traumatic conditions affect the bone tissue. Most of those pathological conditions are specific and different among different patients, such as bone defects due to traumatic injuries or bone remodeling alterations due to congenital diseases. In this context, the development of personalized therapies would be highly desirable. In recent years the advent of innovative techniques like bioprinting and microfluidic organ-on-chip raised hopes of achieving key tools helping the application of personalized therapies for bone diseases. In this review we will illustrate the latest progresses in the bioprinting of personalized bone grafts and generation of patient-specific bone-on-chip devices, describing current approaches and limitations and possible future improvements for more effective personalized bone grafts and disease models.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Engineered in vitro disease models have already made incredible progress in academic and pharmaceutical R&D settings, thanks to the high-level engineering approaches which enable one to replicate organ-like complexity and functionality in vitro [202,372–374].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [372]
Citations
Cites
1 retracted
Peng, X., Guo, W., Ren, T., Lou, Z., Lu, X., Zhang, S., Lu, Q., & Sun, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058361 · Cited by 94
RetractedBhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
A 3D bioprinting system to produce human-scale tissue constructs with structural integrity
Kang, H.-W., Lee, S. J., Ko, I. K., Kengla, C., Yoo, J. J., & Atala, A. (2016) · Nature Biotechnology · doi:10.1038/nbt.3413 · Cited by 2,622
Cell-laden microengineered gelatin methacrylate hydrogels
Nichol, J. W., Koshy, S. T., Bae, H., Hwang, C. M., Yamanlar, S., & Khademhosseini, A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.064 · Cited by 2,377
3D bioprinting for engineering complex tissues
Mandrycky, C., Wang, Z., Kim, K., & Kim, D.-H. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.12.011 · Cited by 1,754
Feng, X., & McDonald, J. M. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130203 · Cited by 1,272
Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip
Zhang, Y. S., Arneri, A., Bersini, S., Shin, S.-R., Zhu, K., Goli-Malekabadi, Z., Aleman, J., Colosi, C., Busignani, F., Dell'Erba, V., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.003 · Cited by 951
Self-citationMicrofluidic Bioprinting of Heterogeneous 3D Tissue Constructs Using Low‐Viscosity Bioink
Colosi, C., Shin, S. R., Manoharan, V., Massa, S., Costantini, M., Barbetta, A., Dokmeci, M. R., Dentini, M., & Khademhosseini, A. (2016) · Advanced Materials · doi:10.1002/adma.201503310 · Cited by 863
Journal of Biomedical Materials Research Part A
(2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/(issn)1552-4965 · Cited by 739
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Self-citation
Cited by
Advancing Frontiers in Bone Bioprinting
Ashammakhi, N., Hasan, A., Kaarela, O., Byambaa, B., Sheikhi, A., Gaharwar, A. K., & Khademhosseini, A. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801048 · Cited by 244
Organ‐on‐chip models: Implications in drug discovery and clinical applications
Mittal, R., Woo, F. W., Castro, C. S., Cohen, M. A., Karanxha, J., Mittal, J., Chhibber, T., & Jhaveri, V. M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27729 · Cited by 234
“Bone and cancer models have been primarily studied for prostate, breast, and lung cancer metastasis (Arrigoni et al., 2017).”
BackgroundCardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals
Serrano, D. R., Kara, A., Yuste, I., Luciano, F. C., Ongoren, B., Anaya, B. J., Molina, G., Diez, L., Ramirez, B. I., Ramirez, I. O., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020313 · Cited by 192
“In this case, the platform goes up as the layers are formed, and the platform is progressively raised according to the dimensions of each layer to be printed [19,30,53].”
BackgroundTumor heterogeneity: preclinical models, emerging technologies, and future applications
Proietto, M., Crippa, M., Damiani, C., Pasquale, V., Sacco, E., Vanoni, M., & Gilardi, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1164535 · Cited by 172
“Although the so-far described strategies provide a valuable complement to traditional preclinical models in the study of tumor invasiveness or drug effects concerning specific DNA aberrations, they lack the representation of the stromal compartment which plays a crucial role in cell spatial distribution, growth, invas…”
BackgroundSelf-citation
Metadata
- Authors
- Arrigoni, C., Gilardi, M., Bersini, S., Candrian, C., & Moretti, M.
- Affiliations
- IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT)
- Ente Ospedaliero Cantonale (CH)
- Swiss Institute for Regenerative Medicine (CH)
- Corresponding author
- Moretti, Matteo
- Venue
- Stem Cell Reviews and Reports
- Published
- 2017-06
- Volume
- 13
- Issue
- 3
- Pages
- 407-417
- ISSN
- 1550-8943 (ISSN-L)
- 1558-6804
- OpenAlex
- W2621684241
- Cited by
- 68
- References
- 85
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 8 · 2019: 10 · 2018: 6 · 2017: 2
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Stem Cell Reviews and Reports (publishedVersion)
- PubMed (publishedVersion)
- Funders
- USA department of defense Breast Cancer Research Program (W81XWH-15-1-0092)
- Italian Ministry of Health
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Physical Sciences › Engineering › Biomedical Engineering › Anatomy and Medical Technology
- Keywords
- bioprinting, organ-on-a-chip, personalized medicine, bone disease, microfluidics, bone defects, bone remodeling, disease models, patient-specific therapy
- MeSH terms
- Animals, Bone and Bones, Bone Diseases, Humans, Lab-On-A-Chip Devices, Precision Medicine, Bioprinting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases. https://app.cochat.ai/papers/10.1007/s12015-017-9741-5
- The paper
- Arrigoni, C., Gilardi, M., Bersini, S., Candrian, C., & Moretti, M. (2017). Bioprinting and Organ-on-Chip Applications Towards Personalized Medicine for Bone Diseases. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-017-9741-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.